REGISTERED NUMBER: 11343093 (England and Wales)

Unaudited Financial Statements

for the Year Ended 30th November 2025

for

P & J Healthcare Ltd

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

Mr P A Hunt

Mrs J M Hunt

REGISTERED OFFICE:

Woodlands Grange

Woodlands Lane

Bradley Stoke

Bristol

United Kingdom

BS32 4JY

REGISTERED NUMBER:

11343093 (England and Wales)

ACCOUNTANTS:

Dunkley's

Woodlands Grange

Woodlands Lane

Bradley Stoke

Bristol

United Kingdom

BS32 4JY

FIXED ASSETS

Investments

4

780,427

780,427

CURRENT ASSETS

Debtors

5

261,571

362,218

Cash at bank

6

678

780

262,249

362,998

CREDITORS

Amounts falling due within one year

7

257,031

357,001

NET CURRENT ASSETS

5,218

5,997

TOTAL ASSETS LESS CURRENT LIABILITIES

785,645

786,424

CAPITAL AND RESERVES

Called up share capital

9

1,000

1,000

Share premium

10

387,689

387,689

Retained earnings

10

396,956

397,735

SHAREHOLDERS' FUNDS

785,645

786,424

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th November 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th November 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3rd September 2026 and were signed on its behalf by:

Mr P A Hunt - Director

1.	STATUTORY INFORMATION

P & J Healthcare Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are presented in Pound Sterling (£), which is the company's functional and presentation currency.

Critical accounting judgements and key sources of estimation uncertainty

The directors consider that there are no critical judgements or key sources of estimation uncertainty that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year.

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost.

Financial instruments

The Company has elected to apply the provisions of Section 11 'Basic Financial Instruments'. Financial instruments are recognised in the Company's balance sheet when the Company becomes party to the contractual provisions of the instrument.

Basic financial assets

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are initially measured at transaction price (including transaction costs) and subsequently measured at amortised cost using the effective interest method, less any impairment.

Basic financial liabilities

Short-term creditors are measured at transaction price. Other financial liabilities, including bank loans and other loans, are initially measured at transaction price (including transaction costs) and subsequently measured at amortised cost using the effective interest method.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Going concern

The financial statements have been prepared on a going concern basis. The directors have considered the company’s financial position and are satisfied that it will be able to meet its liabilities as they fall due for a period of at least twelve months from the date of approval of these financial statements.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

4.	FIXED ASSET INVESTMENTS

Shares in

group

undertakings

£

COST

At 1st December 2024

and 30th November 2025

780,427

NET BOOK VALUE

At 30th November 2025

780,427

At 30th November 2024

780,427

The company's investments at the Balance Sheet date in the share capital of companies include the following:

P & H Healthcare Ltd

Registered office: United Kingdom

Nature of business: Operation of a pharmacy

%

Class of shares:

holding

Ordinary

100.00

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.11.25

30.11.24

£

£

Amounts owed by group undertakings

261,571

362,218

6.	CASH AT BANK

30.11.25

30.11.24

£

£

Bank account no. 1

678

780

Cash and cash equivalents consist solely of balances held in the Company's bank accounts. The Company does not hold any short-term investments and does not operate an overdraft facility.

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.11.25

30.11.24

£

£

Directors' current accounts

256,468

356,468

Accrued expenses

563

533

257,031

357,001

8.	SECURED DEBTS

There were no secured debts at the year end.

9.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

30.11.25

30.11.24

value:

£

£

1,000

Ordinary

£1

1,000

1,000

10.

RESERVES

Retained

Share

earnings

premium

Totals

£

£

£

At 1st December 2024

397,735

387,689

785,424

Profit for the year

33,221

33,221

Dividends

(34,000

)

(34,000

)

At 30th November 2025

396,956

387,689

784,645

11.	CONTINGENT LIABILITIES

The company had no contingent liabilities at the balance sheet date.

12.	OTHER FINANCIAL COMMITMENTS

At the balance sheet date the company had no capital or other financial commitments.

13.	RELATED PARTY DISCLOSURES

During the year, the company entered into the following transactions with related parties:

Director’s loan account: At the year end, the company owed £256,468 (2024: £356,468) to the directors. The balance is unsecured, interest-free and repayable on demand.

Amounts owed by group undertakings: At the year end, P & H Healthcare Ltd, the company's subsidiary undertaking, owed £261,571 (2024: £362,218) to the company. The balance is unsecured, interest-free and repayable on demand.

14.	POST BALANCE SHEET EVENTS

Subsequent to the year end the company disposed of its entire shareholding in P & H Healthcare Ltd. The agreed consideration under the share purchase agreement was £1.1 million plus an adjustment for completion net current assets. As completion occurred after the reporting date, the disposal has been treated as a non-adjusting post balance sheet event and no adjustment has been made to the carrying value of the investment at 30 November 2025.